These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 12746761

  • 21. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
    Dornhorst A, Lüddeke HJ, Sreenan S, Koenen C, Hansen JB, Tsur A, Landstedt-Hallin L.
    Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
    [Abstract] [Full Text] [Related]

  • 22. Metabolic control in patients with type 2 diabetes using Humalog Mix50 injected three times daily: crossover comparison with human insulin 30/70.
    Schernthaner G, Kopp HP, Ristic S, Muzyka B, Peter L, Mitteregger G.
    Horm Metab Res; 2004 Mar; 36(3):188-93. PubMed ID: 15057674
    [Abstract] [Full Text] [Related]

  • 23. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL, Ratner RE, Kim DD, Qu Y, Fechner LL, Lenox SM, Holcombe JH.
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [Abstract] [Full Text] [Related]

  • 24. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
    Roach, Koledova E, Metcalfe S, Hultman C, Milicevic Z, Romania/Russia Mix25 Study Group.
    Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
    [Abstract] [Full Text] [Related]

  • 25. Differences in pharmacokinetics and pharmacodynamics of insulin lispro and aspart in healthy volunteers.
    von Mach MA, Brinkmann C, Hansen T, Weilemann LS, Beyer J.
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):416-9. PubMed ID: 12518253
    [Abstract] [Full Text] [Related]

  • 26. Effects of regular insulin or insulin LISPRO on glucose metabolism after an oral glucose load in patients with type 2 diabetes mellitus.
    Paquot N, Roulin D, Schneiter P, Ruiz J, Lefebvre P, Pahud P, Tappy L.
    Diabetes Metab; 1998 Dec; 24(6):523-8. PubMed ID: 9932219
    [Abstract] [Full Text] [Related]

  • 27. Factors associated with switching from oral hypoglycaemic agents to insulin therapy.
    Spoelstra JA, Stol RP, de Bruyne MC, Erkens JA, Herings RM, Leufkens HG, Grobbee DE.
    Neth J Med; 2002 Jul; 60(6):243-8. PubMed ID: 12365467
    [Abstract] [Full Text] [Related]

  • 28. Improved metabolic control preserved beta-cell function two years after diagnosis of insulin-dependent diabetes mellitus.
    Montanya E, Fernandez-Castañer M, Soler J.
    Diabetes Metab; 1997 Sep; 23(4):314-9. PubMed ID: 9342545
    [Abstract] [Full Text] [Related]

  • 29. Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes.
    Hanefeld M, Haffner SM, Menschikowski M, Koehler C, Temelkova-Kurktschiev T, Wildbrett J, Fischer S.
    Diabetes Res Clin Pract; 2002 Mar; 55(3):221-7. PubMed ID: 11850098
    [Abstract] [Full Text] [Related]

  • 30. [The short-acting insulin analog Lispro (Humalog) in the treatment of diabetes--comparison of preprandial and postprandial administration and comparison with treatment using Humulin R].
    Perusicová J, Svehelka JM.
    Vnitr Lek; 1998 Jul; 44(7):409-14. PubMed ID: 9748877
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes.
    Garg S, Rosenstock J, Silverman BL, Sun B, Konkoy CS, de la Peña A, Muchmore DB.
    Diabetologia; 2006 May; 49(5):891-9. PubMed ID: 16506054
    [Abstract] [Full Text] [Related]

  • 32. Early preprandial hypoglycemia after administration of insulin lispro.
    Iafusco D, Angius E, Prisco F.
    Diabetes Care; 1998 Oct; 21(10):1777-8. PubMed ID: 9773751
    [No Abstract] [Full Text] [Related]

  • 33. Sex differences in insulin dose and postprandial glucose as BMI increases in patients with type 2 diabetes.
    Jovanovic L.
    Diabetes Care; 2009 Dec; 32(12):e148. PubMed ID: 19940211
    [No Abstract] [Full Text] [Related]

  • 34. The human insulin analog insulin lispro improves insulin binding on circulating monocytes of intensively treated insulin-dependent diabetes mellitus patients.
    Jehle PM, Fussgaenger RD, Kunze U, Dolderer M, Warchol W, Koop I.
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2319-27. PubMed ID: 8964871
    [Abstract] [Full Text] [Related]

  • 35. Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients.
    Alvarsson M, Sundkvist G, Lager I, Henricsson M, Berntorp K, Fernqvist-Forbes E, Steen L, Westermark G, Westermark P, Orn T, Grill V.
    Diabetes Care; 2003 Aug; 26(8):2231-7. PubMed ID: 12882841
    [Abstract] [Full Text] [Related]

  • 36. Pharmacodynamics and pharmacokinetics of intravenous glibenclamide in Caucasian and Chinese patients with type-2 diabetes.
    Jönsson A, Chan JC, Rydberg T, Vaaler S, Hallengren B, Cockram CS, Critchley JA, Melander A.
    Eur J Clin Pharmacol; 2000 Jan; 55(10):721-7. PubMed ID: 10663449
    [Abstract] [Full Text] [Related]

  • 37. Risk factors for steroid diabetes in rheumatic patients.
    Raúl Ariza-Andraca C, Barile-Fabris LA, Frati-Munari AC, Baltazár-Montufar P.
    Arch Med Res; 1998 Jan; 29(3):259-62. PubMed ID: 9775461
    [Abstract] [Full Text] [Related]

  • 38. Comparison of standard (self-directed) versus intensive patient training for the human insulin inhalation powder (HIIP) delivery system in patients with type 2 diabetes: efficacy, safety, and training measures.
    Rosenstock J, Nakano M, Silverman BL, Sun B, de la Peña A, Suri A, Muchmore DB.
    Diabetes Technol Ther; 2007 Feb; 9(1):80-8. PubMed ID: 17316102
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes.
    Jönsson A, Hallengren B, Rydberg T, Melander A.
    Diabetes Obes Metab; 2001 Dec; 3(6):403-9. PubMed ID: 11903411
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.